{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:13:38Z","timestamp":1792707218568,"version":"4.5.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"4","content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0019133","type":"journal-article","created":{"date-parts":[[2011,4,29]],"date-time":"2011-04-29T17:26:51Z","timestamp":1304098011000},"page":"e19133","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":87,"title":["Preclinical Models for Neuroblastoma: Establishing a Baseline for Treatment"],"prefix":"10.1371","volume":"6","author":[{"given":"Tal","family":"Teitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Stanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cori L.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiakun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa D.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Sedlacik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei M.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Frase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerold E.","family":"Rehg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia M.","family":"Hillenbrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Finkelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Dyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M.","family":"Lahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,4,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma.","volume":"362","author":"JM Maris","year":"2010","journal-title":"N Engl J Med"},{"key":"ref2","first-page":"659","article-title":"A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage.","volume":"75","author":"JC Hoehner","year":"1996","journal-title":"Lab Invest"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Neuroblastoma.","volume":"369","author":"JM Maris","year":"2007","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/onc.2009.518","article-title":"Molecular pathogenesis of peripheral neuroblastic tumors.","volume":"29","author":"I Janoueix-Lerosy","year":"2010","journal-title":"Oncogene"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","article-title":"The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.","volume":"27","author":"SL Cohn","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1200\/JCO.2008.16.6876","article-title":"The International Neuroblastoma Risk group (INRG) staging system: an INRG task Force report.","volume":"27","author":"T Monclair","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1200\/JCO.1998.16.6.2003","article-title":"Stage 4S neuroblastoma: what makes it special?","volume":"16","author":"KK Matthay","year":"1998","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1200\/JCO.2007.12.3349","article-title":"Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97.","volume":"26","author":"B Hero","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1126\/science.6719137","article-title":"Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.","volume":"224","author":"GM Brodeur","year":"1984","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.neo.7900146","article-title":"Detection of MYCN gene amplification in neuroblastoma by florescence in situ hybridization: a pediatric oncology group study.","volume":"3","author":"P Mathew","year":"2001","journal-title":"Neoplasia"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1158\/0008-5472.CAN-05-0854","article-title":"The MYCN enigma: significance of MYCN expression in neuroblastoma.","volume":"66","author":"XX Tang","year":"2006","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1101\/gad.1067003","article-title":"Genomic targets of the human c-myc protein.","volume":"17","author":"PC Fernandez","year":"2003","journal-title":"Genes Dev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e8154","DOI":"10.1371\/journal.pone.0008154","article-title":"Global MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-Box Motifs and regions of DNA hypermethylation.","volume":"4","author":"DM Murphy","year":"2009","journal-title":"PLoS ONE"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng.2007.30","article-title":"Widespread microRNA repression by MYC contributes to tumorigenesis.","volume":"40","author":"TC Chang","year":"2008","journal-title":"Nat Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1158\/0008-5472.CAN-06-3667","article-title":"Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis.","volume":"67","author":"Y Chen","year":"2007","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ijc.23153","article-title":"MYCN regulates oncogenic microRNAs in neuroblastoma.","volume":"122","author":"JH Schulte","year":"2008","journal-title":"Int J Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1002\/ijc.25436","article-title":"Accurate prediction of neuroblastoma outcome based on miRNA expression profiles.","volume":"127","author":"JH Schulte","year":"2010","journal-title":"Int J Cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1093\/emboj\/16.11.2985","article-title":"Targeted expression of MYCN causes neuroblastoma in transgenic mice.","volume":"16","author":"WA Weiss","year":"1997","journal-title":"EMBO J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/jcp.2007.054627","article-title":"Histological profile of tumors from MYCN transgenic mice.","volume":"61","author":"HC Moore","year":"2008","journal-title":"J Clin Pathol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"12664","DOI":"10.1073\/pnas.0401083101","article-title":"Mechanisms of embryonal tumor initiation: Distinct roles for MycN expression and MYCN amplification.","volume":"101","author":"LM Hansford","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref21","first-page":"5266","article-title":"Genome-wide array CGH analysis of murine neuroblastoma reveals distinct genomic aberrations which parallel those in human tumors.","volume":"63","author":"CS Hackett","year":"2003","journal-title":"Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ejca.2007.03.008","article-title":"Cell lines from MYCN transgenic murine tumors reflect the molecular and biological characteristics of human neuroblastoma.","volume":"43","author":"AJ Cheng","year":"2007","journal-title":"Eur J Cancer"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/75007","article-title":"Caspase-8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN.","volume":"6","author":"T Teitz","year":"2000","journal-title":"Nat Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1593\/neo.08778","article-title":"Chemotherapy-induced apoptosis in a transgenic model of neuroblastoma proceeds through p53 induction.","volume":"10","author":"L Chesler","year":"2008","journal-title":"Neoplasia"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1593\/neo.09466","article-title":"Mdm2 deficiency suppresses MYCN-driven neuroblastoma tumorigenesis In Vivo.","volume":"11","author":"Z Chen","year":"2009","journal-title":"Neoplasia"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1158\/0008-5472.CAN-08-2968","article-title":"Targeting ornithine decarboxylase impairs development of MYCN-amplified neuroblastoma.","volume":"69","author":"RJ Rounbehler","year":"2009","journal-title":"Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/cncr.20005","article-title":"Large cell neuroblastoma.","volume":"100","author":"T Tornoczky","year":"2004","journal-title":"Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/cncr.20717","article-title":"Enlarged and prominent nucleoli may be indicative of MYCN amplification.","volume":"103","author":"C Kobayashi","year":"2005","journal-title":"Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02940304","article-title":"Pathology of peripheral neuroblastic tumors: Significance of prominent nucleoli in undifferentiated\/poorly differentiated neuroblastoma.","volume":"13","author":"T Tornoczky","year":"2007","journal-title":"Pathol Oncol Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.","volume":"4","author":"D Huang","year":"2009","journal-title":"Nat Protoc"},{"key":"ref31","first-page":"21","article-title":"Neuroblastoma cell lines.","author":"CJ Thiele","year":"1998"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.bbamcr.2006.06.014","article-title":"Evaluation of IFN-gamma effects on apoptosis and gene expression in neuroblastoma\u2013preclinical studies.","volume":"1763","author":"TM Tekautz","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1128\/MCB.02357-06","article-title":"Chk1-mediated phosphorylation of FANCE is required for the Fanconi Anemia\/BRCA pathway.","volume":"27","author":"X Wang","year":"2007","journal-title":"Mol Cell Bio"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.dnarep.2009.04.012","article-title":"Taking the time to make important decisions: The checkpoint effector kinases Chk1 and Chk2 and the DNA damage response.","volume":"8","author":"TH Stracker","year":"2009","journal-title":"DNA Repair"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2353\/ajpath.2009.090019","article-title":"MYCN promotes the expansion of Phox2B-Positive neuronal progenitors to drive neuroblastoma development.","volume":"175","author":"G Alam","year":"2009","journal-title":"Am J Pathol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jpedsurg.2007.02.027","article-title":"In vivo bioluminescence imaging for early detection and monitoring of disease progression in a murine model of neuroblastoma.","volume":"42","author":"PV Dickson","year":"2007","journal-title":"J Pediatr Surg"},{"key":"ref37","first-page":"3595","article-title":"Design and setup of dynamic contrast enhanced experiments for longitudinal preclinical studies of tumor response to antiangiogenic therapy.","volume":"17","author":"J Sedlacik","year":"2009","journal-title":"Proc Intl Soc Mag Reson Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/jmri.20676","article-title":"Quantitative dynamic contrast-enhanced MRI in tumor-bearing rats and mice with inversion recovery TrueFISP and two contrast agents at 4.7 T.","volume":"24","author":"C Weidensteiner","year":"2006","journal-title":"J Magn Reson Imaging"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/mrm.1910030602","article-title":"RARE imaging: a fast imaging method for clinical MR.","volume":"3","author":"J Hennig","year":"1986","journal-title":"Magn Reson Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1148\/radiology.212.3.r99se34876","article-title":"Abdominal MR imaging with a volumetric interpolated breath-hold examination.","volume":"212","author":"NM Rofsky","year":"1999","journal-title":"Radiology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data.","volume":"4","author":"RA Irizarry","year":"2003","journal-title":"Biostatistics"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0019133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T07:31:29Z","timestamp":1560151889000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0019133"}},"subtitle":[],"editor":[{"given":"Paul","family":"Dent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,4,29]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,4,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0019133","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,29]]}}}